Global /India /Healthcare /Drug Manufacturers - General /523144

Medi-Caps Ltd.

523144 (MEDICAPQ)

• BSE: 523144 • Delayed

27.92INR 2.5%

0.2957 USD

As of 20 June 2026, Medi-Caps Ltd. has a market cap of $3.69M USD, ranking #45569 globally and #4124 in India. It ranks #4036 in the Healthcare sector, and #1296 in the Drug Manufacturers - General industry.

Global Rank

45569

Country Rank

4124

Sector Rank

4036

Industry Rank

1296

Key Stats

Market Cap

$3.69MUSD

348.16M INR

Enterprise Value

$1.04MUSD

97.85M INR

Revenue (TTM)

$1.69MUSD

159.63M INR

EBITDA (TTM)

-$803.17KUSD

-75.83M INR

Net Income (TTM)

-$462.05KUSD

-43.61M INR

EBITDA Margin

-48%

Profit Margin

-27%

PS Ratio

2.2

PB Ratio

0.3

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Alok Garg open_in_new

Employees

Founded

1983

Website

medicaps.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.5%	-7.7%	13%	-1.9%	-33%	-13%	-35%	-28%	-36%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	523144 (MEDICAPQ) Medi-Caps Ltd ISIN: INE442D01010 Shares Out.: Shares Outstanding: 12.47M¹ TV: TradingView: BSE: MEDICAPQ SA: Stock Analysis: BOM: 523144 YF: Yahoo Finance: 523144.BO GF: Google Finance: BOM: 523144 BA: Barron's: 523144 MS: Morningstar: XBOM: 523144	27.92 INR	TV: TradingView: BSE: MEDICAPQ SA: Stock Analysis: BOM: 523144 YF: Yahoo Finance: 523144.BO GF: Google Finance: BOM: 523144 BA: Barron's: 523144 MS: Morningstar: XBOM: 523144

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Medi-Caps Ltd.

Medi-Caps Limited engages in the real estate business in India. The company was incorporated in 1983 and is based in Indore, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 1M%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 498K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 411K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 318K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 267K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 263K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 21M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 15M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 10M%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 9M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 8M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 7M%	15.1	United States

chevron_leftBack